Compounding Pharmacy · Chandler, AZ · 503B

Tailstorm Health (Medivant Health) Review

Tailstorm Health Inc., doing business as Medivant Health, is an FDA-registered 503B outsourcing facility in the Phoenix/Chandler, Arizona area that compounded sterile semaglutide and tirzepatide injections. It received an FDA warning letter in April 2025 for cGMP and sterility violations and missing labeling on its GLP-1 products.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

503BFDA Registered 503B
Location: Chandler, AZ
States licensed: 0
5.0
★★★☆☆2.5/5

Editorial score · methodology

Top-Rated GLP-1 Partners

Not sourced from Tailstorm Health (Medivant Health) — these are our highest-scored vetted telehealth partners for compounded GLP-1s, if you'd rather start with a provider we've walked through end to end.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

No insurance needed · HSA/FSA eligible · vetted by our editors

7.1

Bodybuilding Health+

Fitness-brand compounded GLP-1 with hormone and performance programs

Starting price: $179/mo

Get started →Read review Bodybuilding Health+ →
7.4

Brightmeds

Compounded or brand GLP-1 bundled with TRT and peptides for men

Starting price: $189/mo

Get started →Read review Brightmeds →
6.4

Direct Meds

Listed for disclosure only — see its FDA warning and BBB complaints first

Starting price: $249/mo

Get started →Read review Direct Meds →
7.6

Maximus

Men seeking compounded GLP-1 alongside testosterone optimization

Starting price: $199.99/mo

Get started →Read review Maximus →

Certifications & Compliance

All sterile compounding pharmacies in the United States are required to follow United States Pharmacopeia General Chapter <797> sterile compounding standards[4], with finished preparations evaluated against USP <71> sterility testing[5] and USP <85> bacterial endotoxin testing[6] as appropriate for the product type.

FDA Registered 503B
Registered directly with the FDA as a 503B outsourcing facility. Subject to FDA inspection and required to follow cGMP standards.

Drugs Produced

Compounding pharmacies' ability to produce semaglutide or tirzepatide depends on the FDA Drug Shortage List status for each reference product; compounding eligibility can change when a drug moves on or off the shortage list[7].

Semaglutide
Compounded semaglutide produced
Tirzepatide
Compounded tirzepatide produced

States Licensed

Tailstorm Health (Medivant Health) has not published a state-by-state licensure list. Verify licensure for your state directly with your state board of pharmacy before filling a prescription here.

Regulatory Actions

2025-04-08
FDA Warning Letter (FEI 703497) issued to Tailstorm Health Inc. dba Medivant Health following a Sept-Oct 2024 inspection, citing cGMP violations resulting in adulterated products, sterile products prepared under unsanitary conditions, missing required label statements on Semaglutide and Tirzepatide injections, and failure to submit adverse event reports.

Weight Loss Rankings Score Breakdown

Accreditation & Compliance6/10
Regulatory Standing5/10
State Coverage0/10
GLP-1 Production10/10
Track Record5/10

Scores are independently researched. See our methodology for details.

High confidence · Last verified 2026-06-04 via manual · How we verify provider data

Frequently Asked Questions

Tailstorm Health (Medivant Health) is a 503B compounding pharmacy based in Chandler, AZ. It operates under state board of pharmacy licensure. Note: our records show 1 documented regulatory action(s) — see the Regulatory Actions section below.
Tailstorm Health (Medivant Health) is headquartered in Chandler, AZ. The pharmacy is licensed to ship to 0 US states.
Tailstorm Health (Medivant Health) produces compounded semaglutide and compounded tirzepatide in addition to other compounded preparations. As a 503B pharmacy, it can batch-produce sterile compounds under FDA cGMP standards.
503A pharmacies prepare compounded medications for individual patients in response to specific prescriptions and are regulated primarily by state boards of pharmacy under USP <797> sterile compounding standards. 503B outsourcing facilities register directly with the FDA, follow current Good Manufacturing Practices (cGMP), and can produce compounded medications in larger batches without patient-specific prescriptions. 503B facilities are subject to FDA inspection.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

See Top Semaglutide ProvidersAll Pharmacies
Sources & methodology — as of September 2026
  1. 1.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  2. 2.FDA — 503B Outsourcing Facility Registration and Requirements— U.S. Food & Drug Administration.
  3. 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  4. 4.USP General Chapter <797> — Pharmaceutical Compounding: Sterile Preparations— United States Pharmacopeia.
  5. 5.USP General Chapter <71> — Sterility Tests— United States Pharmacopeia.
  6. 6.USP General Chapter <85> — Bacterial Endotoxins Test— United States Pharmacopeia.
  7. 7.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.